• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

证据表明:重复经颅磁刺激是一种有效、安全且耐受性良好的治疗重度抑郁症患者的方法。

The evidence is in: Repetitive transcranial magnetic stimulation is an effective, safe and well-tolerated treatment for patients with major depressive disorder.

机构信息

Epworth Centre for Innovation in Mental Health, Epworth Healthcare, Camberwell, VIC, Australia.

Department of Psychiatry, Monash University, Melbourne, VIC, Australia.

出版信息

Aust N Z J Psychiatry. 2022 Jul;56(7):745-751. doi: 10.1177/00048674211043047. Epub 2021 Aug 28.

DOI:10.1177/00048674211043047
PMID:34459284
Abstract

Despite more than 25 years of research establishing the antidepressant efficacy of repetitive transcranial magnetic stimulation, there remains uncertainty about the depth and breadth of this evidence base, resulting in confusion as to where repetitive transcranial magnetic stimulation fits in the therapeutic armamentarium in the management of patients with mood disorders. The purpose of this article is to provide a concise description of the evidence base supporting the use of repetitive transcranial magnetic stimulation in the context of the stages of research that typically accompanies the development of evidence for a new therapy. The antidepressant efficacy for the use of repetitive transcranial magnetic stimulation in the treatment of depression has been established through a relatively traditional pathway beginning with small case series, progressing to single-site clinical trials and then to larger multisite randomised double-blind controlled trials. Antidepressant effects have been confirmed in numerous meta-analyses followed more recently by large network meta-analysis and umbrella reviews, with evidence that repetitive transcranial magnetic stimulation may have greater efficacy than alternatives for patients with treatment-resistant depression. Finally, repetitive transcranial magnetic stimulation has been shown to produce meaningful response and remission rates in real-world samples of greater than 5000 patients. The evidence for the antidepressant efficacy of repetitive transcranial magnetic stimulation therapy is overwhelming, and it should be considered a routine part of clinical care wherever available.

摘要

尽管已有 25 多年的研究证明重复经颅磁刺激具有抗抑郁作用,但对于这一证据基础的深度和广度仍存在不确定性,导致人们对于在治疗心境障碍患者的治疗武器库中重复经颅磁刺激的位置感到困惑。本文的目的是在通常伴随着新疗法证据发展的研究阶段的背景下,对支持重复经颅磁刺激应用的证据基础进行简要描述。在治疗抑郁症方面,重复经颅磁刺激的抗抑郁疗效已经通过相对传统的途径得到确立,从小型病例系列开始,逐步发展到单中心临床试验,然后是更大规模的多中心随机双盲对照试验。大量荟萃分析证实了抗抑郁作用,随后又进行了大型网络荟萃分析和伞式综述,有证据表明重复经颅磁刺激对治疗抵抗性抑郁症患者可能比其他替代方法更有效。最后,重复经颅磁刺激在超过 5000 名患者的真实样本中显示出了有意义的反应和缓解率。重复经颅磁刺激治疗的抗抑郁疗效证据确凿,在有条件的地方,应将其视为临床常规治疗的一部分。

相似文献

1
The evidence is in: Repetitive transcranial magnetic stimulation is an effective, safe and well-tolerated treatment for patients with major depressive disorder.证据表明:重复经颅磁刺激是一种有效、安全且耐受性良好的治疗重度抑郁症患者的方法。
Aust N Z J Psychiatry. 2022 Jul;56(7):745-751. doi: 10.1177/00048674211043047. Epub 2021 Aug 28.
2
Revisiting the effectiveness of repetitive transcranial magnetic stimulation treatment in depression, again.再次探讨重复经颅磁刺激治疗抑郁症的疗效。
Aust N Z J Psychiatry. 2022 Aug;56(8):905-909. doi: 10.1177/00048674211068788. Epub 2021 Dec 30.
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Repetitive transcranial magnetic stimulation for post-traumatic stress disorder in adults.重复经颅磁刺激治疗成人创伤后应激障碍。
Cochrane Database Syst Rev. 2024 Aug 2;8(8):CD015040. doi: 10.1002/14651858.CD015040.pub2.
5
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
6
Vortioxetine for depression in adults.伏硫西汀用于成人抑郁症治疗。
Cochrane Database Syst Rev. 2017 Jul 5;7(7):CD011520. doi: 10.1002/14651858.CD011520.pub2.
7
New generation antidepressants for depression in children and adolescents: a network meta-analysis.新一代抗抑郁药治疗儿童和青少年抑郁症:网络荟萃分析。
Cochrane Database Syst Rev. 2021 May 24;5(5):CD013674. doi: 10.1002/14651858.CD013674.pub2.
8
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial.普拉克索联合心境稳定剂治疗难治性双相抑郁:PAX - BD随机双盲安慰剂对照试验
Health Technol Assess. 2025 May;29(21):1-216. doi: 10.3310/HBFC1953.
9
Antidepressants for the treatment of depression in people with cancer.用于治疗癌症患者抑郁症的抗抑郁药。
Cochrane Database Syst Rev. 2018 Apr 23;4(4):CD011006. doi: 10.1002/14651858.CD011006.pub3.
10
Personalized brain functional sectors guided theta burst transcranial magnetic stimulation for treatment-resistant depression: a study protocol for a multi-centre, randomised, double-blind, sham-controlled clinical trial.个性化脑功能区引导的theta波爆发式经颅磁刺激治疗难治性抑郁症:一项多中心、随机、双盲、假对照临床试验的研究方案
BMJ Open. 2025 Jul 6;15(7):e098155. doi: 10.1136/bmjopen-2024-098155.

引用本文的文献

1
Facilitators and barriers to participation of patients with treatment resistant depression in a randomised controlled trial of two forms of personalised magnetic resonance imaging targeted transcranial magnetic stimulation (the BRIGhTMIND trial).难治性抑郁症患者参与两种形式的个性化磁共振成像靶向经颅磁刺激随机对照试验(BRIGhTMIND试验)的促进因素和障碍
BMC Psychiatry. 2025 Jul 25;25(1):728. doi: 10.1186/s12888-025-06893-2.
2
Effects of TMS on anhedonia and suicidal ideation in treatment-resistant depression: Outcomes from the University of Minnesota Interventional Psychiatry Program.经颅磁刺激对难治性抑郁症中快感缺乏和自杀观念的影响:明尼苏达大学介入精神病学项目的结果
J Mood Anxiety Disord. 2024 May 31;8:100073. doi: 10.1016/j.xjmad.2024.100073. eCollection 2024 Dec.
3
Transdiagnostic Attentional Deficits Are Associated with Depressive and Externalizing Symptoms in Children and Adolescents with Neuropsychiatric Disorders.跨诊断注意力缺陷与患有神经精神疾病的儿童和青少年的抑郁及外化症状相关。
Arch Clin Neuropsychol. 2025 May 21;40(4):783-793. doi: 10.1093/arclin/acae103.
4
Investigating the effects of excitatory and inhibitory somatosensory rTMS on somatosensory functioning in the acute and subacute phases of stroke: a preliminary double-blind and randomized trial.研究兴奋性和抑制性体感重复经颅磁刺激对中风急性期和亚急性期体感功能的影响:一项初步双盲随机试验。
Front Hum Neurosci. 2024 Sep 30;18:1474212. doi: 10.3389/fnhum.2024.1474212. eCollection 2024.
5
Utilization and outcomes of transcranial magnetic stimulation and usual care for MDD in a large group psychiatric practice.在一个大型精神病学实践中,经颅磁刺激和常规护理用于治疗 MDD 的利用情况和结果。
BMC Psychiatry. 2024 Jul 9;24(1):497. doi: 10.1186/s12888-024-05928-4.
6
Never Too Late: Safety and Efficacy of Deep TMS for Late-Life Depression.为时未晚:深部经颅磁刺激治疗老年期抑郁症的安全性与有效性
J Clin Med. 2024 Jan 31;13(3):816. doi: 10.3390/jcm13030816.
7
10 Hz repetitive transcranial magnetic stimulation (rTMS) may improve cognitive function: An exploratory study of schizophrenia patients with auditory hallucinations.10赫兹重复经颅磁刺激(rTMS)可能改善认知功能:一项针对伴有幻听的精神分裂症患者的探索性研究。
Heliyon. 2023 Sep 9;9(9):e19912. doi: 10.1016/j.heliyon.2023.e19912. eCollection 2023 Sep.
8
Accelerated Repetitive Transcranial Magnetic Stimulation to Treat Major Depression: The Past, Present, and Future.加速重复经颅磁刺激治疗重度抑郁症:过去、现在和未来。
Harv Rev Psychiatry. 2023;31(3):142-161. doi: 10.1097/HRP.0000000000000364.
9
Medicare Benefits Schedule item numbers for transcranial magnetic stimulation (TMS): Questions arising.医疗保险福利计划项目编号用于经颅磁刺激(TMS):问题出现。
Australas Psychiatry. 2023 Aug;31(4):494-496. doi: 10.1177/10398562231173228. Epub 2023 May 2.
10
Current Status of Neuromodulation-Induced Cortical Prehabilitation and Considerations for Treatment Pathways in Lower-Grade Glioma Surgery.神经调节诱导的皮质预康复现状及低级别胶质瘤手术治疗途径的考量
Life (Basel). 2022 Mar 22;12(4):466. doi: 10.3390/life12040466.